Europe Microbiome Therapeutics Market

Europe Microbiome Therapeutics Market size was valued at USD 1.8 billion in 2025 and is forecast to grow from USD 2.1 billion in 2026 to reach USD 4.3 billion by 2031, at a CAGR of 19.3%.

Description

The Europe Microbiome Therapeutics Market size was valued at USD 1.8 billion in 2025 and is forecast to grow from USD 2.1 billion in 2026 to reach USD 4.3 billion by 2031, at a CAGR of 19.3%. Microbiome therapeutics encompasses live biotherapeutic products, prebiotics, probiotics, postbiotics, and fecal microbiota transplantation therapies used to modulate microbial community composition and restore gut ecosystem balance across gastrointestinal, infectious disease, oncology, and mental health indications, ranging from regulated pharmaceutical-grade biotherapeutics to advanced clinical-stage microbiome drug candidates. The market sits at the intersection of microbiology, immunology, and precision medicine, making it one of the most rapidly advancing enabling categories across the regional biopharmaceuticals and clinical therapeutics value chain.

Demand for microbiome therapeutics products and services remains anchored by rising gastrointestinal disorder prevalence, growing scientific recognition of gut-brain axis and immune modulation mechanisms, and expanding clinical pipeline investment across Germany, France, the United Kingdom, and Switzerland. Beyond gastrointestinal applications, microbiome therapeutics continues to enable treatment approaches in oncology supportive care, antibiotic-resistant infection management, and mental health modulation that require accurate, clinically validated microbiome intervention solutions. Increasing regulatory clarity from the European Medicines Agency on live biotherapeutic product approval pathways, expanding venture capital investment in microbiome drug development, and continued microbiome research infrastructure development are sustaining consumption even as the region transitions toward more targeted, disease-specific microbiome intervention frameworks.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Europe Microbiome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product (Live Biotherapeutic Products, Prebiotics, Probiotics, Postbiotics, Others)

      2. By Application (Gastrointestinal Disorders, Infectious Diseases, Oncology, Mental Health, Others)

      3. By End User (Home Care Settings, Hospitals & Clinics, Diagnostic Laboratories, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • Germany Microbiome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • United Kingdom Microbiome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • France Microbiome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Switzerland Microbiome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Belgium Microbiome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Europe Microbiome Therapeutics Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Seres Therapeutics Inc.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. Ferring Pharmaceuticals

    3. Vedanta Biosciences Inc.

    4. Enterome SA

    5. Pendulum Therapeutics Inc.

    6. 4D Pharma plc

    7. Synlogic Inc.

    8. Evonik Industries AG

    9. Biocodex SA

    10. NextBiotix Inc.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology